SOCS3 and COVID-19: Individuals in the COVID-19 group showed higher expression of OAS1 (p = 0.0002), MAVS (p = 0.0001) and SOCS3 transcripts (p = 0.001) as compared to HC (Fig 3C-3D,3H).